While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
14h
FOX 2 Detroit on MSNDetroit area teen takes part in groundbreaking type 1 diabetes study using 100-year-old TB vaccineFOX 2 - A 100-year-old vaccine is getting a fresh look as it's being studied to treat an autoimmune disease. One local child who's hoping to help change the world for people with type 1 diabetes.
19h
GlobalData on MSNMedtronic stock down 5% as surgical unit offsets ablation and diabetes growthMedtronic posted a strong profit for Q3 of fiscal year 2025, though shares were down as its cardiac ablation product success ...
5h
abp LIVE on MSNUnexplained Hypertension? THIS Mineral Helps Maintain Blood Pressure And It Is Not Sodium Or PotassiumApart from other risk factors for hypertension such as genetics, advancing age, obesity, stress, and insulin resistance, poor ...
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
We recently compiled a list of the 12 Best Internet of Things Stocks To Buy According to Analysts. In this article, we are going to take a look at where DexCom, Inc.
Besides it being a free way to get some movement in, there are myriad benefits to walking every day. Third Space master ...
Energy bars have come a long way since they took off in the 1980s. Early brands like Clif Bar and PowerBar were marketed as ...
15h
Investor's Business Daily on MSNWhy Medtronic Just Undercut Its Buy Zone With A 7% DropMedtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.
The US Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being received.
13h
Interesting Engineering on MSNFDA approves first-ever rapid-acting insulin biosimilar for diabetes treatmentFirst-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results